Cite
HARVARD Citation
Matsutani, T. et al. (2013). SAT0101 Abatacept Treatment Suppresses T Cell Activation in Anti-Cyclic Citrullinated Peptide Antibody (ACPA) Positive RA Patients but not in Acpa Negative RA Patients. Annals of the rheumatic diseases. p. A614. [Online].